校正:基于MnO2的纳米粒子重塑瘤微环境,以增强针对乳腺癌的声动力免疫疗法
Haiqin Liao1,2,3,4, Mingyu Chen2,3,4, Zhipeng Liao2,3,4
1Department of Ultrasound, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China. niuchengcheng@csu.edu.cn.
Biomaterials science
|March 11, 2026
概括
这项修正澄清了对基于二氧化 (MnO2) 的纳米粒子的发现. 这些纳米粒子重塑瘤微环境,以增强乳腺癌治疗的声动力免疫疗法.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 瘤微环境 (TME) 对有效的癌症免疫疗法构成重大障碍.
- 声动力免疫疗法 (SDT) 提供了一种有希望的方法来克服TME的挑战.
- 开发新型纳米材料对于提高SDT有效性至关重要.
研究的目的:
- 纠正和澄清有关MnO2基纳米颗粒的发现.
- 详细说明这些纳米颗粒如何重塑TME以增强乳腺癌SDT.
- 提供关于实现的治疗增强的准确数据.
主要方法:
- 基于MnO2的纳米颗粒的合成和表征.
- 评估TME调制的体外和体内研究.
- 在乳腺癌模型中评估声动力学治疗的疗效和安全性.
主要成果:
- 纠正与纳米粒子功能相关的特定数据点和解释.
- 通过MnO2纳米颗粒成功进行TME重塑的演示.
- 在乳腺癌的声动力免疫疗法中提高治疗结果.
结论:
- 经过校正的结果再次证实了MnO2纳米粒子在TME重塑中的潜力.
- 这种方法显著提高了声动力学免疫治疗对乳腺癌的疗效.
- 准确的报告对于纳米医学在癌症治疗中的进步至关重要.
相关概念视频
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K